(18)F-FECH-PET/CT has been proved to be an imaging agent for prostate carcinoma. However, its role in detecting the bone metastases is still blurred owing to the lack of related studies. The purpose of our study was to assess the efficacy of PET with (18)F-ethylcholine in assessing the bone status and to compare the results with that of conventional bone scan findings. For this purpose, we sele...

INTRODUCTION Prostate cancer is the second most common neoplasm among men both worldwide and in Poland. In prostate cancer, bone metastasis is related to a poorer prognosis. A diagnosis of metastatic bone disease is important in prostate cancer patients prior to therapy. Prostate specific antigen (PSA) serum value is used both as a screening tool and for staging of prostate cancer. AIM To eva...

  A 57-year-old male with history of prostatectomy, cyctectomy, cecal urinary diversion for invasive prostate cancer and with a recent rise in PSA level, was referred for bone scintigraphy to rule out osseous metastatic disease. An interesting finding was abnormal tracer accumulation throughout the large bowel, which was proved to be due to urinary diversion.

DESCRIPTION A 54-year-old patient underwent right radical nephrectomy for what was then diagnosed as a Stage-II (T2bN0M0) renal cell carcinoma (RCC). Four months after surgery, the patient reported of pelvic pain and had a rising serum alkaline-phosphatase level. The tecnetium-99 mmethylene-diphosphate (Tc99m-MDP) bone scan then demonstrated a focus of uptake in the right ischium, corresponding...

Leukemia is the most common childhood cancer and accounts for 30-40% of all malignancies. A retrospective review  was performed of the hospital records of 9 children, 6 boys and 3 girls, aged  from 2.5 to 15 years with ALL initially referred to Nemazee hospital Nuclear medicine center for whole body bone scanning between 2000 and 2002. Bone marrow pathology established ALL (L1) in two and ALL (...

21 TNM Staging of Non–Small Cell Lung Cancer: Comparison of PET/MR and PET/CT Martin W. Huellner, Felipe de Galiza Barbosa, Lars Husmann, Carsten M. Pietsch, Cäcilia E. Mader, Irene A. Burger, Paul Stolzmann, Gaspar Delso, Thomas Frauenfelder, Gustav K. von Schulthess, and Patrick Veit-Haibach 27 Phase I Study of Ga-HER2-Nanobody for PET/CT Assessment of HER2 Expression in Breast Carcinoma Marl...